Abstract
Abstract
This study aims to associate the incidence of postoperative vasoplegia and short-term survival to the implantation of various left ventricular assist devices differing in hemocompatibility and flow profiles. The overall incidence of vasoplegia was 25.3% (73/289 patients) and 30.3% (37/122), 25.0% (18/72), and 18.9% (18/95) in the axial flow (AXF), centrifugal flow (CF), and centrifugal flow with artificial pulse (CFAP) group, respectively. Vasoplegia was associated with longer intensive care (ICU) and hospital length of stay (LOS) and mortality. ICU and in-hospital LOS and 1-year mortality were the lowest in the CFAP group. Post hoc analysis resulted in a p-value of 0.43 between AXF and CF; 0.35 between CF and CFAP; and 0.06 between AXF and CFAP. Although there is a trend in diminished incidence of vasoplegia, pooled logistic regression using flow profile and variables that remained after feature selection showed that flow profile was not an independent predictor for postoperative vasoplegia.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
2. Florisson DS, Conte SM, De Bono JA, Newcomb AE. Interact Cardiovasc Thorac Surg. 2019;29:844–51.
3. Zimpfer D, Gustafsson F, Potapov E, et al. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE registry. Eur Heart J. 2020;41:3801–9.
4. Numan L, Ramjankhan FZ, Oberski DL, et al. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support. ESC Heart Fail. 2021;8:1596–603.
5. Felix SEA, Oerlemans MIF, Ramjankhan FZ, et al. One year improvement of exercise capacity in patients with mechanical circulatory support as bridge to transplantation ESC. Heart Fail. 2021;8:1796–805.